Meta Description: Baxter International Inc. records a share price increase with steady fundamentals in the healthcare sector. Investors consider market performance and company profile for insights.
Company Overview
Baxter International Inc., headquartered in Deerfield, Illinois, has been a prominent player in the global healthcare market since its incorporation in 1931. The company operates through subsidiaries delivering medical instruments and supplies in over 100 countries. Its portfolio includes dialysis therapies, intravenous therapies, infusion devices, critical care products, parenteral nutrition, biological products, and surgical solutions. Baxter also offers connected care solutions and engages in contracted services with pharmaceutical firms, such as its agreement with Celerity Pharmaceutical, LLC.
The company serves diverse settings including hospitals, kidney dialysis centers, nursing homes, and patients at home under physician oversight. This broad coverage places Baxter firmly as a supplier of essential healthcare products worldwide.
Stock Performance
On the New York Stock Exchange (NYSE: BAX), Baxter International Inc. recently closed at USD 23.86, representing a change of +0.63 or a percentage increase of 2.712%. This uptick signals a positive market sentiment following recent trading sessions. The stock’s 52-week range stands between USD 21.33 and USD 38.28, indicating notable volatility over the past year. Such range gives investors a measure of potential risk and reward based on historical performance.
Current trading volume is 5,393,978 shares against an average volume of 7,566,929 shares. Investors often examine this metric to assess market interest and liquidity. Higher liquidity typically facilitates smoother transactions and can attract institutional investors.
Market Position and Sector
Baxter operates in the “Medical – Instruments & Supplies” industry within the broader healthcare sector. The company holds a substantial market capitalization of approximately USD 12.25 billion. Market cap serves as a measure of company size and potential stability, helping stakeholders compare Baxter with peers.
This industry is characterized by steady demand for medical devices and consumables, driven by demographics, chronic disease prevalence, and hospital infrastructure investments.
Governance and Leadership
Under the leadership of CEO David Brent Shafer, Baxter International focuses on delivering reliable healthcare solutions. Effective leadership influences operational efficiency and strategic direction. The company employs around 38,000 full-time employees, underscoring its scale and capacity to sustain global operations.
Strong governance remains essential for compliance in the regulated healthcare environment. Baxter’s longevity in the market reflects management’s ability to adapt while maintaining core product quality.
Key Financial Data
Investors review several key indicators when analyzing Baxter’s financial position:
- Share Price: USD 23.86 – Reflects current market perception of company value.
- Market Capitalization: USD 12.25 billion – Positions Baxter as a large-cap entity in its sector.
- Dividend: USD 0.68 – Signals commitment to returning value to shareholders.
- 52-Week Range: USD 21.33 to USD 38.28 – Shows volatility and potential price movement envelope.
- Volume: 5,393,978 – Compared to average volume of 7,566,929, indicating moderate trading activity.
Dividend payout attracts income-focused investors and indicates consistent cash flow. Market capitalization influences both risk profile and investor base. Price range and volume provide context on stock stability and trading dynamics.
Trading Details
Baxter trades on the New York Stock Exchange under the ticker BAX. Identification codes include ISIN US0718131099, CUSIP 071813109, and CIK 0000010456. These identifiers are crucial in regulatory filings, cross-border trading, and institutional portfolio management.
The shares are actively traded and the company is not classified as an ETF, ADR, or fund.
FAQ
- What dividend does Baxter International pay? Baxter currently pays a dividend of USD 0.68 per share.
- How many people work at Baxter? Baxter has approximately 38,000 full-time employees worldwide.
- Where is Baxter headquartered? Baxter’s headquarters are located at One Baxter Parkway, Deerfield, IL 60015, United States.
- On which exchange is Baxter listed? Baxter trades on the New York Stock Exchange under the symbol BAX.
- What sector and industry does Baxter belong to? Healthcare sector, Medical – Instruments & Supplies industry.
Conclusion
Baxter International’s recent share price increase underscores investor attention within the healthcare sector. With a large-cap market position, diversified product lines, and global reach, the company maintains relevance in a highly regulated and essential industry. Dividend payouts and a broad portfolio support its investment appeal, while trading metrics show steady market engagement.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult a licensed advisor before making investment decisions.
Announcement
For full information about the company, see the link below.